
Several
in vitro protein-synthesizing systems
have been used in recent years for the translation of viral, prokaryotic, as
well as eukaryotic messenger ribonucleic acids (mRNAs). Of these, the rabbit
reticulocyte lysate, the Krebs ascites fluid (both of animal origin), and the
wheat germ extract have received the most attention. However, these systems are
not representative of eukaryotic cells in the way they regulate translation.
They cannot or do not respond to various physiological (eg: hormones, toxins,
ions), chemical, and other external (heat shock, magnetic fields) stimuli which
are important regulators of cellular functions in nucleated cells, and they
cannot be used for studies on viral infection. In addition to these widely used
systems, cell-free extracts originating from a variety of eukaryotic cell types
have been generated for the translation of mRNAs or to study aspects of the
regulation of protein synthesis. The generation of an efficient protein-synthesizing system obtained
from eukaryotic cells that have grown as monolayers has been hampered for a
long time by the lack of translatability of exogenously added mRNAs, and by the
loss of biological activities after freeze/thawing. Indeed,
the successful generation of a translational extract obtained from eukaryotic
cells that have grown as monolayers has an important potential: i)
it can be employed in place of the mostly
used commercially available rabbit reticulocyte lysate; ii)
it is a
priori preferable, since no living animals are required for its generation
through experimental chronic anemia; iii)
the cells grown as monolayers in small
volumes of cell culture medium, and not as large scale suspension cultures, can
be preincubated with hormones, toxins, ions, thus allowing modulation of
biological processes prior to extract preparation; iv)
the cells can be infected with viruses
prior to extract preparation; v)
the translation extract allows both
cap-dependent and cap-independent translation; vi)
in the presence of sucrose, it allows
freeze/thawing without loss of activity, here the translatability of
exogenously added mRNAs, a features that can be extended to various biological
samples for the preservation of their respective enzymatic activities. vii)
It can lead to the study of the fate of
the HCV IRES in vitro. |

Figure. In
vitro translation in a micrococcal nuclease-treated cytoplasmic extract
obtained from BHK cells that have grown as monolayers. Translation of exogenous
CAT-EMC-LUC (lane 2), CAT-HCV [E1-∆E2] (lane 3) capped, polycistronic
mRNAs. Translation without exogenous mRNA (lane 1).
Chloramphenicol-acetyl-transferase (CAT), luciferase (LUC), HCV structural
(HCV) polypeptides. No exogenous microsomal membranes were added in the
translation reactions. Mr, relative molecular mass. It is of crucial relevance to employ a biologically active, dimeric creatine kinase for the generation of a translational extract allowing the translation on the exogenous messenger RNAs. For this, the creatine kinase has first to be reactivated with the use of a reducing agent, such as dithiothreitol.
The relevance
of such a method for in vitro
translation studies as documented in this published article on various mRNAs, such
as here hepatitis C virus mRNA, thus deserve special emphasis. |